Innovation Beyond Therapeutics: Diagnostics and AI
Supported by NIH grants, private funding, and a comprehensive patent portfolio, Cytonic aims to bring the first disease-modifying OA therapy to the market — addressing a $393 billion global opportunity.
For updates and detailed information, visit https://cytonics.com.
Top comments (0)